According to a different study, patients with NSCLC who have high levels of the mRNAs SLC2A1, SLC2A2, SLC2A3, SLC2A4, SLC2A5, SLC2A6, SLC2A7, SLC2A9, SLC2A11, and SLC2A14 have a considerably worse overall survival (Du et al., 2020). Here, SLC2A9 is linked to non-small cell lung carcinoma.